These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
786 related items for PubMed ID: 30382301
1. Prognostic analysis of interim 18F-FDG PET/CT in patients with diffuse large B cell lymphoma after one cycle versus two cycles of chemotherapy. Yuan L, Kreissl MC, Su L, Wu Z, Hacker M, Liu J, Zhang X, Bo Y, Zhang H, Li X, Li S. Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):478-488. PubMed ID: 30382301 [Abstract] [Full Text] [Related]
2. Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma. Li X, Sun X, Li J, Liu Z, Mi M, Zhu F, Wu G, Lan X, Zhang L. Cancer Med; 2019 Sep; 8(11):5012-5022. PubMed ID: 31293092 [Abstract] [Full Text] [Related]
3. Predictive value of Dmax and %ΔSUVmax of 18F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma. Dang J, Peng X, Wu P, Yao Y, Tan X, Ye Z, Jiang X, Jiang X, Liu Y, Chen S, Cheng Z. BMC Med Imaging; 2023 Oct 31; 23(1):173. PubMed ID: 37907837 [Abstract] [Full Text] [Related]
7. Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method. Rekowski J, Hüttmann A, Schmitz C, Müller SP, Kurch L, Kotzerke J, Franzius C, Weckesser M, Bengel FM, Freesmeyer M, Hertel A, Krohn T, Holzinger J, Brink I, Haberkorn U, Nyuyki F, van Assema DME, Geworski L, Hasenclever D, Jöckel KH, Dührsen U. J Nucl Med; 2021 Jan 31; 62(1):37-42. PubMed ID: 32385164 [Abstract] [Full Text] [Related]
8. Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma. Kim J, Lee JO, Paik JH, Lee WW, Kim SE, Song YS. Ann Nucl Med; 2017 Jan 31; 31(1):1-11. PubMed ID: 27627889 [Abstract] [Full Text] [Related]
10. (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. Mylam KJ, Kostakoglu L, Hutchings M, Coleman M, Lamonica D, Czuczman MS, Diehl LF, Nielsen AL, Jensen P, Loft A, Hendel HW, Iyer V, Leppä S, Jyrkkiö S, Holte H, Eriksson M, Gillstrøm D, Hansen PB, Seppänen M, Hjorthaug K, Brown Pde N, Pedersen LM. Leuk Lymphoma; 2015 Jul 31; 56(7):2005-12. PubMed ID: 25330442 [Abstract] [Full Text] [Related]
11. Predicting diffuse large B-cell lymphoma outcomes with lesion-to-liver maximum standardized uptake value for interim-treatment and end-of-treatment positron emission tomography-computed tomography. Wang L, Zhang S, Xin J. Quant Imaging Med Surg; 2023 Oct 01; 13(10):6789-6800. PubMed ID: 37869355 [Abstract] [Full Text] [Related]
13. [Prognostic Value of Interim PET/CT in 227 Patients of DLBCL]. Wang RM, Li F, Liu CB, Guan ZW, Fu LP, Xu BX, Zhu HY. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb 01; 27(1):74-79. PubMed ID: 30738450 [Abstract] [Full Text] [Related]
15. Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial. Itti E, Blanc-Durand P, Berriolo-Riedinger A, Kanoun S, Kraeber-Bodéré F, Meignan M, Gat E, Gouill SL, Casasnovas RO, Bodet-Milin C. J Nucl Med; 2023 Nov 01; 64(11):1706-1711. PubMed ID: 37734837 [Abstract] [Full Text] [Related]
17. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma. Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO. Cancer Biother Radiopharm; 2016 Dec 01; 31(10):361-365. PubMed ID: 27996313 [Abstract] [Full Text] [Related]